Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-06

FDA Approved: SUMATRIPTAN SUCCINATE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals' Sumatriptan Succinate as an Original Application (ANDA), marking the first generic approval of sumatriptan succinate for a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan succinate (Sumatriptan succinate)

Snippet

ORIG AP for SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)